Watch Now: Calidi Biotherapeutics and City of Hope announce first patients dosed in a Phase 1 clinical trial
→
Company
Company
About
History
Team
Careers
Medical & Scientific Advisors
Board of Advisors
Our Science
How It Works
Novel Platform
Publications
Medical & Scientific Advisors
Board of Advisors
Our Science
Pipeline
Newsroom
Investors
English
Contact
Publication
Abstract 6542: CAL1 vaccinia virus as oncolytic agent and potential use of cell-based platform to enhance its therapeutic effects
American Association for Cancer Research
August 15, 2020
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more
A talented, seasoned group of world-class executives, doctors, and scientists producing revolutionary work.
Learn more